These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 31977292)

  • 1. SWI/SNF Complex Mutations in Gynecologic Cancers: Molecular Mechanisms and Models.
    Wang Y; Hoang L; Ji JX; Huntsman DG
    Annu Rev Pathol; 2020 Jan; 15():467-492. PubMed ID: 31977292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The novel reversible LSD1 inhibitor SP-2577 promotes anti-tumor immunity in SWItch/Sucrose-NonFermentable (SWI/SNF) complex mutated ovarian cancer.
    Soldi R; Ghosh Halder T; Weston A; Thode T; Drenner K; Lewis R; Kaadige MR; Srivastava S; Daniel Ampanattu S; Rodriguez Del Villar R; Lang J; Vankayalapati H; Weissman B; Trent JM; Hendricks WPD; Sharma S
    PLoS One; 2020; 15(7):e0235705. PubMed ID: 32649682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hereditary SWI/SNF complex deficiency syndromes.
    Agaimy A; Foulkes WD
    Semin Diagn Pathol; 2018 May; 35(3):193-198. PubMed ID: 29397238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Convergent structural alterations define SWItch/Sucrose NonFermentable (SWI/SNF) chromatin remodeler as a central tumor suppressive complex in pancreatic cancer.
    Shain AH; Giacomini CP; Matsukuma K; Karikari CA; Bashyam MD; Hidalgo M; Maitra A; Pollack JR
    Proc Natl Acad Sci U S A; 2012 Jan; 109(5):E252-9. PubMed ID: 22233809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SWI/SNF protein expression status in fumarate hydratase-deficient renal cell carcinoma: immunohistochemical analysis of 32 tumors from 28 patients.
    Agaimy A; Amin MB; Gill AJ; Popp B; Reis A; Berney DM; Magi-Galluzzi C; Sibony M; Smith SC; Suster S; Trpkov K; Hes O; Hartmann A
    Hum Pathol; 2018 Jul; 77():139-146. PubMed ID: 29689242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The spectrum of SWI/SNF mutations, ubiquitous in human cancers.
    Shain AH; Pollack JR
    PLoS One; 2013; 8(1):e55119. PubMed ID: 23355908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SWI/SNF chromatin remodeling and human malignancies.
    Masliah-Planchon J; Bièche I; Guinebretière JM; Bourdeaut F; Delattre O
    Annu Rev Pathol; 2015; 10():145-71. PubMed ID: 25387058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual loss of the SWI/SNF complex ATPases SMARCA4/BRG1 and SMARCA2/BRM is highly sensitive and specific for small cell carcinoma of the ovary, hypercalcaemic type.
    Karnezis AN; Wang Y; Ramos P; Hendricks WP; Oliva E; D'Angelo E; Prat J; Nucci MR; Nielsen TO; Chow C; Leung S; Kommoss F; Kommoss S; Silva A; Ronnett BM; Rabban JT; Bowtell DD; Weissman BE; Trent JM; Gilks CB; Huntsman DG
    J Pathol; 2016 Feb; 238(3):389-400. PubMed ID: 26356327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular context determines DNA methylation profiles in SWI/SNF-deficient cancers of the gynecologic tract.
    Kommoss FK; Tessier-Cloutier B; Witkowski L; Forgo E; Koelsche C; Köbel M; Foulkes WD; Lee CH; Kolin DL; von Deimling A; Howitt BE
    J Pathol; 2022 Jun; 257(2):140-145. PubMed ID: 35218556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The genetic alteration spectrum of the SWI/SNF complex: The oncogenic roles of BRD9 and ACTL6A.
    Sima X; He J; Peng J; Xu Y; Zhang F; Deng L
    PLoS One; 2019; 14(9):e0222305. PubMed ID: 31504061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Remodeling the cancer epigenome: mutations in the SWI/SNF complex offer new therapeutic opportunities.
    Orlando KA; Nguyen V; Raab JR; Walhart T; Weissman BE
    Expert Rev Anticancer Ther; 2019 May; 19(5):375-391. PubMed ID: 30986130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SWI/SNF Complexes in Ovarian Cancer: Mechanistic Insights and Therapeutic Implications.
    Fukumoto T; Magno E; Zhang R
    Mol Cancer Res; 2018 Dec; 16(12):1819-1825. PubMed ID: 30037854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinico-pathological significance of TCGA classification and SWI/SNF proteins expression in undifferentiated/dedifferentiated endometrial carcinoma: A possible prognostic risk stratification.
    Santoro A; Angelico G; Travaglino A; Raffone A; Arciuolo D; D'Alessandris N; Inzani F; Zannoni GF
    Gynecol Oncol; 2021 May; 161(2):629-635. PubMed ID: 33712277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inactivating mutations in SWI/SNF chromatin remodeling genes in human cancer.
    Oike T; Ogiwara H; Nakano T; Yokota J; Kohno T
    Jpn J Clin Oncol; 2013 Sep; 43(9):849-55. PubMed ID: 23904343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SMARCA4 loss irrelevant for
    Wagner SK; Moon AS; Howitt BE; Renz M
    Gynecol Oncol Rep; 2023 Dec; 50():101305. PubMed ID: 38033359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BAFfling pathologies: Alterations of BAF complexes in cancer.
    Arnaud O; Le Loarer F; Tirode F
    Cancer Lett; 2018 Apr; 419():266-279. PubMed ID: 29374542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SWI/SNF-mutant cancers depend on catalytic and non-catalytic activity of EZH2.
    Kim KH; Kim W; Howard TP; Vazquez F; Tsherniak A; Wu JN; Wang W; Haswell JR; Walensky LD; Hahn WC; Orkin SH; Roberts CW
    Nat Med; 2015 Dec; 21(12):1491-6. PubMed ID: 26552009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular pathways: SWI/SNF (BAF) complexes are frequently mutated in cancer--mechanisms and potential therapeutic insights.
    Wang X; Haswell JR; Roberts CW
    Clin Cancer Res; 2014 Jan; 20(1):21-7. PubMed ID: 24122795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SWI/SNF-deficiency defines highly aggressive undifferentiated endometrial carcinoma.
    Tessier-Cloutier B; Coatham M; Carey M; Nelson GS; Hamilton S; Lum A; Soslow RA; Stewart CJ; Postovit LM; Köbel M; Lee CH
    J Pathol Clin Res; 2021 Mar; 7(2):144-153. PubMed ID: 33125840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The SWI/SNF complex subunit genes: Their functions, variations, and links to risk and survival outcomes in human cancers.
    Savas S; Skardasi G
    Crit Rev Oncol Hematol; 2018 Mar; 123():114-131. PubMed ID: 29482773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.